Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Liposarcoma, Myxoid 1Liposarcoma 1Lipoma 1

Interventions

High-Throughput Nucleotide Sequencing 2Base Sequence 2trametinib 1spartalizumab 1ribociclib 1palbociclib 1olaparib 1nilotinib 1glasdegib 1futibatinib 1durvalumab 1dabrafenib 1ceritinib 1capmatinib 1camrelizumab 1Radiotherapy 1Nivolumab 1Lapatinib 1Irinotecan 1Ipilimumab 1Environment 1Doxorubicin 1Docetaxel 1Cryosurgery 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Sarcoma × ribociclib × Clear all
NCT03096912 2017-10-25

A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
30 enrolled
Sarcoma

Lipoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡